Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Shaoul

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|June 29, 2017
Loss of CD55 in Eculizumab-Responsive Protein-Losing EnteropathyAlina Kurolap, Orly Eshach-Adiv, Tova Hershkovitz, et al.
Journal of Crohn'S & Colitis|November 23, 2017
Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD StudyNoa Cohen-Dolev, Malgorata Sladek, Seamus Hussey, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 22, 2018
Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and NutritionSalvatore Oliva, Mike Thomson, Lissy de Ridder, et al.
Journal of Crohn'S & Colitis|March 22, 2018
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHANOren Ledder, Amit Assa, Arie Levine, et al.
Journal of Crohn'S & Colitis|June 13, 2017
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHANOren Ledder, Amit Assa, Arie Levine, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2021
Monitoring Enables Progress: A Nationwide Quality Improvement Program in Children With Crohn DiseaseDotan Yogev, Adi Shosberger, Chen Nehemia, et al.
Journal of Crohn'S & Colitis|June 5, 2019
Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH StudyArie Levine, Neil Chanchlani, Seamus Hussey, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 8, 2017
Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHANJorge Amil-Dias, Sanja Kolacek, Dan Turner, et al.
Inflammatory Bowel Diseases|December 31, 2013
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD groupLissy de Ridder, Dan Turner, David C Wilson, et al.
Journal of Crohn'S & Colitis|July 1, 2023
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHANNoa Tal, Christos Tzivinikos, Marco Gasparetto, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|June 29, 2017
Loss of CD55 in Eculizumab-Responsive Protein-Losing EnteropathyAlina Kurolap, Orly Eshach-Adiv, Tova Hershkovitz, et al.
Journal of Crohn'S & Colitis|November 23, 2017
Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD StudyNoa Cohen-Dolev, Malgorata Sladek, Seamus Hussey, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 22, 2018
Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and NutritionSalvatore Oliva, Mike Thomson, Lissy de Ridder, et al.
Journal of Crohn'S & Colitis|March 22, 2018
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHANOren Ledder, Amit Assa, Arie Levine, et al.
Journal of Crohn'S & Colitis|June 13, 2017
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHANOren Ledder, Amit Assa, Arie Levine, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2021
Monitoring Enables Progress: A Nationwide Quality Improvement Program in Children With Crohn DiseaseDotan Yogev, Adi Shosberger, Chen Nehemia, et al.
Journal of Crohn'S & Colitis|June 5, 2019
Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH StudyArie Levine, Neil Chanchlani, Seamus Hussey, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 8, 2017
Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHANJorge Amil-Dias, Sanja Kolacek, Dan Turner, et al.
Inflammatory Bowel Diseases|December 31, 2013
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD groupLissy de Ridder, Dan Turner, David C Wilson, et al.
Journal of Crohn'S & Colitis|July 1, 2023
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHANNoa Tal, Christos Tzivinikos, Marco Gasparetto, et al.
Pageof 18